miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC.
Jingushi K, Ueda Y, Kitae K, Hase H, Egawa H, Ohshio I, Kawakami R, Kashiwagi Y, Tsukada Y, Kobayashi T, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K.
Jingushi K, et al. Among authors: hase h.
Mol Cancer Res. 2015 Mar;13(3):565-74. doi: 10.1158/1541-7786.MCR-14-0300. Epub 2014 Nov 7.
Mol Cancer Res. 2015.
PMID: 25381221